Radnet, Inc. · NASDAQ:RDNT

Radnet — Merger or Acquisition (April 2025)

13 slides from Radnet's merger presentation, Apr 15, 2025

  1. Slide 1: Strategic Acquisition Discussion

    Strategic Acquisition Discussion April 16, 2025

  2. Slide 2: No Offer or Solicitation

    No Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or s

  3. Slide 3: Forward-Looking Statements

    Forward - Looking Statements This communication contains certain “forward - looking statements” within the meaning of the safe harbor provisions of the U . S . Private Securities Litigation Reform Act of 1995 , Section 27 A of the Securities Act and Section 21 E of the Securities Exchange Act of 193

  4. Slide 4: RadNet introductions

    Mark Stolper Executive Vice President and Chief Financial Officer, RadNet , Inc. Kees Wesdorp , PhD President and Chief Executive Officer, RadNet Digital Health Sham Sokka , PhD Chief Operations and Technology Officer, RadNet Digital Health Sanjog Misra Chief Commercial Officer, RadNet Digital Healt

  5. Slide 5: RadNet already demonstrates leadership in breast cancer detection

    • RadNet performs ~1.9M mammograms per year, 4.4% of all mammograms in US , and 50,000+ breast biopsies per year • RadNet’s Enhanced Breast Cancer Detection program – powered by DeepHealth’s SmartMammo AI – enables 21% higher cancer detection rate 1 across all races and ages and lowers recall rates

  6. Slide 6: iCAD, a global leader in AI-powered breast health solutions

    Annual Revenue $ 19.6M FY 24 Their ProFound AI ® Breast Health Suite is a highly accurate, clinically validated, concurrent AI reader designed to assist in early breast cancer detection, density assessment, and short - term risk by analysing mammogram images in real time. 50+ Countries Served 1. 5 K

  7. Slide 7: RadNet has signed a definitive agreement to acquire iCAD

    The acquisition will strengthen RadNet’s DeepHealth leadership in AI - driven Breast Cancer solutions by: • Accelerating scale across commercial, product, and engineering functions to meet growing market demand. • Expanding reach to a combined 10 million annual mammograms, over 1,700 provider sites,

  8. Slide 8: Financial Overview

    • 2024 actuals: $19.6M • Following the acquisition expected positive Adjusted EBITDA run rate by end of 2026 2 • 2025 guidance: $80 - 90M 1 • 2025 guidance: $15 - 17M Adjusted EBITDA 1 2 Revenue Earnings 1 Guidance issued as of February 27, 2025, and not being reaffirmed or updated hereby. 2 Adjuste

  9. Slide 9: Acquisition expected to create attractive potential synergies

    Commercial synergies Cost synergies • DeepHealth offerings into iCAD installed base • Access to 50+ countries, European growth acceleration in screening solutions • Shared funnel opportunities • $7M+ run rate cost synergies identified: ~$ 4M direct savings, e.g., board of directors, public company c

  10. Slide 10: iCAD personnel expected to accelerate DeepHealth's growth plans

    • Strong track record with global reach to develop, market, deploy, and service AI solutions at scale. • Partially fulfilling pre - existing hiring plans of DeepHealth to drive external growth. 26 FTE 26 FTE 14 FTE Product and R&D* Commercial** Support functions iCAD workforce, total 66 FTE 1 * Incl

  11. Slide 11: Most comprehensive Breast AI Portfolio

    Integrated Viewing & Reporting AI - powered Cancer Detection End to End Solution for Screening 1 Previously known as Assure. Safeguard Review Value Most comprehensive Breast AI Portfolio From AI only to complete technology stack for s creening Clinical Impact Workflow Efficiency Revenue Generation P

  12. Slide 12: Transaction summary

    • Under the terms of the merger agreement, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger. • Based upon RadNet’s closing price on Monday, April 14, 2025, this represents a transaction value of approximate

  13. Slide 13: (RadNet

    (RadNet digitalhealth

RadNet — Merger or Acquisition (April 2025) on 6ix